Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
PACS Group
(NYSE:PACS)
Intraday
$28.21
0
[0.00%]
After-Hours
$28.21
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$28.21
0
[0.00%]
At close: May 17
$28.21
0
[0.00%]
PreMarket: 4:36PM EDT
Get Report
Watch
Q1 2024 Earnings were released on Mon May 13th, after the market close
The most recent conference call was at 16:00 PM, 6 days ago
Click to view past webcast
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for PACS Group Stock (NYSE:PACS)
PACS Group Stock (NYSE: PACS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, May 15, 2024
Truist Securities Maintains Buy on PACS Group, Maintains $32 Price Target
Benzinga Newsdesk
-
4 days ago
RBC Capital Maintains Outperform on PACS Group, Raises Price Target to $32
Benzinga Newsdesk
-
4 days ago
Oppenheimer Maintains Outperform on PACS Group, Raises Price Target to $32
Benzinga Newsdesk
-
4 days ago
Tuesday, May 14, 2024
Stephens & Co. Reiterates Overweight on PACS Group, Maintains $31 Price Target
Benzinga Newsdesk
-
5 days ago
PACS Group Q1 EPS $0.38 Beats $0.30 Estimate, Sales $934.72M Beat $892.97M Estimate
Benzinga Newsdesk
-
6 days ago
Monday, May 06, 2024
Stephens & Co. Initiates Coverage On PACS Group with Overweight Rating, Announces Price Target of $31
Benzinga Newsdesk
-
May 6, 2024, 10:27AM
JP Morgan Initiates Coverage On PACS Group with Overweight Rating, Announces Price Target of $27
Benzinga Newsdesk
-
May 6, 2024, 8:49AM
Citigroup Initiates Coverage On PACS Group with Buy Rating, Announces Price Target of $32
Benzinga Newsdesk
-
May 6, 2024, 8:45AM
RBC Capital Initiates Coverage On PACS Group with Outperform Rating, Announces Price Target of $30
Benzinga Newsdesk
-
May 6, 2024, 7:30AM
Truist Securities Initiates Coverage On PACS Group with Buy Rating, Announces Price Target of $32
Benzinga Newsdesk
-
May 6, 2024, 7:21AM
Oppenheimer Initiates Coverage On PACS Group with Outperform Rating, Announces Price Target of $31
Benzinga Newsdesk
-
May 6, 2024, 6:26AM
Tuesday, April 16, 2024
Reported Earlier, PACS Group Successfully Closes Initial Public Offering, Raising $450M And Full Underwriters' Option Exercised
Benzinga Newsdesk
-
Apr 16, 2024, 3:08AM
Thursday, April 11, 2024
PACS Group Prices Upsized $450M Initial Public Offering Of 21,428,572 Common Shares At $21/Share
Benzinga Newsdesk
-
Apr 11, 2024, 3:16AM
Wednesday, April 10, 2024
Pacs Group, Inc IPOs Tomorrow, Here's What You Need To Know
Benzinga Insights
-
Apr 10, 2024, 11:00AM
Sunday, April 07, 2024
A Look At Upcoming IPOs For The Week
Benzinga Insights
-
Apr 7, 2024, 2:39PM
Thursday, August 19, 2010
Symantec Surges in Pre-Market After Successful Test (SYMC)
Benzinga
-
Aug 19, 2010, 9:15AM
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch